Technical Charting - Emcure Pharmaceuticals Ltd.
Search Company
Registered Address
Registered & Corporate Office : Plot No. P-1 and P-2, IT-BT Park, Phase II, M.I.D.C., Hinjawadi,
Pune, Maharashtra - 411057
Tel: 020-35070033, 35070000
Email : investors@emcure.com
Website : http://www.emcure.com
Key Officials
Name Designation
Mr. Chetan Rajendra Sharma Co. Secretary & Compl. Officer
Mr. Tajuddin Sabir Shaikh Chief Financial Officer
Listings
BSE , NSE ,  
Standalone Consolidated
You are viewing standalone data.
Quarterly Results
Dec 24 Sep 24 Jun 24
Sales 1,028.81 1,104.63 970.29
Other Income 19.41 54.93 32.51
Total Expenses 729.09 720.37 696.65
Operating Profit 299.72 384.27 273.64
Interest 19.93 31.40 37.57
Gross Profit 123.90 175.69 110.13
Provisions Made 0.00 0.00 0.00
Depreciation 56.65 56.34 55.08
Taxation 17.05 32.44 14.60
Net Profit / Loss 50.20 86.92 40.45
Equity Capital 189.43 189.10 181.15
Balance Sheet
Mar 24 Mar 23 Mar 22
Share Capital 181.15 180.85 180.85
Reserve & Surplus 1,753.95 1,661.02 1,531.68
Revaluation Reserve 0.00 0.00 0.00
Networth 1,935.10 1,841.87 1,712.53
Total debt 1,414.50 1,667.76 1,573.79
Total Liability 3,349.60 3,509.63 3,286.32
Net Block 1,718.24 1,432.71 1,307.36
Capital work in progress 106.40 253.10 239.25
Investment 684.00 690.02 563.36
Net current asset 840.95 1,133.81 1,176.35
Miscellaneous expenses 0.00 0.00 0.00
Total Assets 3,349.60 3,509.63 3,286.32
Income Statement
  Mar24 Mar23 Mar22
Sales 3,497.66 3,107.09 3,387.24
Other Income 138.26 125.35 132.68
Total Expenses 3,055.77 2,668.59 2,592.58
Operating Profit 441.89 438.49 794.67
Interest 166.09 166.83 145.14
Adjusted PBDIT 580.15 563.84 927.35
Depreciation 204.83 178.52 165.79
Adjusted PBT 209.23 218.48 616.42
Taxation 39.08 52.28 169.61
Net Profit / Loss 160.83 160.06 446.81
Key Ratios
  Mar24 Mar23 Mar22
OPM (%) 12.63 14.11 23.46
GPM (%) 6.77 8.36 18.56
NPM (%) 4.59 5.15 13.19
Earning Retention Ratio 68.12 78.24 87.86
Return on networth (%) 8.31 8.69 26.09
EPS (Rs.) 8.88 8.85 24.71
Dividend payout Ratio 33.73 22.59 12.14
Longterm Debt-Equity Ratio 0.22 0.32 0.29
Current Ratio 1.60 2.02 2.13
Fixed Asset Turnover Ratio 1.02 0.91 0.98
Inventory 1.04 0.88 1.03
Interest coverage Ratio 3.49 3.38 6.39
Registrar Details
MUFG Intime India Pvt. Ltd.
C 101, 247 Park, L.B.S. Marg, Vikhroli (West)
Mumbai,400083,Maharashtra
Tel : 022-49186270
Fax : 49186060
Market Performance
Exchange BSE NSE
Last Traded Price (Rs.) 1,041.65 1,065.50
Last Traded Date 15/05/2025 15/05/2025
Last Traded Time 09:19:00 AM 03:48:47 PM
Change (%) -1.54% 0.94%
Day's Open (Rs.) 1,064.95 1,060.00
Previous Close (Rs.) 1,057.90 1,055.60
Day's High (Rs.) 1,064.95 1,072.50
Day's Low (Rs.) 1,041.65 1,040.00
Volume (Rs. In Lacs) 1.14 653.22
Bid Price (Rs.) 1,040.40 1,065.50
Bid Quantity 2 31
Offer Price (Rs.) 1,044.95 0.00
Offer Quantity 11
Exchange Code 544210 EMCUREEQ
Exchange Group B OtherEQ
Board Meetings
Date Purpose
22/05/2025 Audited Results & Final Dividend
06/02/2025 Quarterly Results
07/11/2024 Quarterly Results
Corporate News
Emcure Pharmaceutica - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Emcure Pharmaceutica - Analysts/Institutional Investor Meet/Con. Call Updates
Emcure Pharmaceutica - Board Meeting Intimation
Emcure Pharmaceutica - Board Meeting Intimation for Approval Of Audited Financial Results (Standalone And Consolidated) For T
Emcure Pharmaceutica - Disclosure under SEBI Takeover Regulations
Share Holding Pattern as on 31/12/2024
Major Holder No. of Shares Percentage (%)
Promoters 147,649,282 77.94
Institutional Investors 13,101,423 6.92
Other Investors 18,947,272 10.00
General Public 9,733,870 5.14